Skip to main
LNTH
LNTH logo

Lantheus Holdings (LNTH) Stock Forecast & Price Target

Lantheus Holdings (LNTH) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Lantheus Holdings Inc is projected to experience significant revenue growth in its PSMA PET imaging segment, with an estimated high-single-digit market share by the first quarter of 2025, reflecting strong upward momentum from previous periods. The company anticipates a reinvigoration of growth for its Pylarify product line, attributed to a new formulary that increases batch sizes by approximately 50% and extends three years of TPT eligibility, effectively enhancing production capacity and potential revenues. Furthermore, improvements in unit and pricing dynamics are expected to materialize through the second half of 2026, supporting a positive outlook for Lantheus's financial performance.

Bears say

Lantheus Holdings Inc. is facing a negative outlook due to its declining growth trajectory, with its two-year growth profile now falling below that of profitable small to mid-cap (SMID) MedTech peers amid lower Pylarify growth forecasts for 2025-2026. The company's Pylarify revenue of $260 million represents an 8% year-over-year decline, which was approximately $14 million short of consensus estimates, marking a significant miss that raises concerns among investors. Additionally, Lantheus experienced lower-than-expected unit growth, achieving only a 2% year-over-year increase, coupled with a notable 10% price headwind during the quarter, further exacerbating the challenges facing its financial performance.

Lantheus Holdings (LNTH) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lantheus Holdings (LNTH) Forecast

Analysts have given Lantheus Holdings (LNTH) a Buy based on their latest research and market trends.

According to 6 analysts, Lantheus Holdings (LNTH) has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lantheus Holdings (LNTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.